Healthcare Services

Mycobacterium Tuberculosis Industry Expansion Forecast Showing Market Size of $4.75 Billion by 2030 at 4.9% CAGR

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Mycobacterium Tuberculosis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The mycobacterium tuberculosis market size has experienced significant expansion in recent years. It is anticipated to increase from $3.73 billion in 2025 to $3.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. The historical growth can be attributed to several factors, including high tb incidence in developing regions, widespread adoption of culture-based testing, increased investment in public health programs, a rise in global disease surveillance, and the early development of pcr-based methods.

The mycobacterium tuberculosis market size is anticipated to experience consistent expansion over the coming years, projected to reach $4.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include the increased application of molecular diagnostics, the broadening of telemedicine-based TB screening initiatives, a surging demand for rapid detection kits, enhanced government funding allocated for TB elimination efforts, and progress in automated detection systems. Key trends anticipated within this timeframe encompass the greater integration of molecular TB diagnostic technologies, the expanded deployment of rapid antigen and antibody test kits, the proliferation of culture-based testing within regions highly affected by TB, an escalating need for TB screening within research and public health programs, and a heightened consumption of reagents and consumables for standard TB testing procedures.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24325&type=smp

What Drivers Are Influencing The Mycobacterium Tuberculosis Market?

Increased investments in research and development are projected to boost the growth of the mycobacterium tuberculosis market in the future. Research and development encompasses the systematic investigation and experimentation conducted to generate new knowledge or improve existing products, services, or technologies. The rise in R&D is driven by rapid technological advancements, creating a need for continuous innovation to remain competitive in evolving global markets. Research and development aids mycobacterium tuberculosis treatment by facilitating the discovery of novel drug candidates that can overcome resistance to current therapies, thereby enhancing treatment effectiveness and patient outcomes. For instance, in March 2024, according to a report from the Foreign, Commonwealth, and Development Office, a UK-based government department, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program. This funding is intended to support innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries, with this support, 500,000 people will receive health care, 37,000 people will have their TB detected, and potentially more than 15,000 lives will be saved. Consequently, the growth of the mycobacterium tuberculosis market will be driven by the rise in investments for research and development.

What Major Segment Divisions Exist Within The Mycobacterium Tuberculosis Market?

The mycobacterium tuberculosis market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Consumables, Software Solutions

2) By Diagnostic Method: Culture-Based Methods, Molecular Diagnosis, Immunological Tests

3) By Route Of Administration: Oral, Injectable

4) By End User: Hospitals, Diagnostic Laboratories, Research Institutions

Subsegments:

1) By Instruments: Diagnostic Instruments, Detection Instruments, Molecular Diagnostic Instruments, Tuberculosis Culture Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Reagents, Tuberculosis Culture Media, Antigen Kits, Test Strips, Tuberculosis Diagnostic Kits

3) By Software Solutions: Laboratory Information Management Systems (LIMS), Diagnostic Software, Data Management Software, Telemedicine Solutions For TB Diagnosis

What Key Trends Are Influencing The Development Of The Mycobacterium Tuberculosis Market?

Leading firms within the mycobacterium tuberculosis market are prioritizing the creation of sophisticated solutions, like automated tuberculosis tests, to provide quicker and more precise outcomes. These automated tuberculosis tests represent diagnostic instruments employing automated systems and cutting-edge technology for the swift and accurate detection of Mycobacterium tuberculosis and its drug resistance, requiring minimal human involvement. As an illustration, in April 2025, Revvity Inc., a US-based biotechnology company, disclosed the U.S. Food and Drug Administration (FDA) gave its approval for the Auto-Pure 2400 liquid handling platform, in conjunction with the T-SPOT TB test. The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test enhances automated tuberculosis testing by facilitating increased volume processing while maintaining accuracy. This system merges liquid handling and magnetic cell isolation technology, processing up to 24 samples per run and finishing Day 1 of testing in under 3.5 hours with very little user intervention. The T-SPOT.TB test, acknowledged by the WHO as the sole ELISPOT-based IGRA, guarantees reproducible results, leading to fewer indeterminate outcomes, a decreased necessity for repeated testing, and dependable performance even in immunocompromised patients.

Which Companies Are Leading Innovation In The Mycobacterium Tuberculosis Market?

Major companies operating in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, Akonni Biosystems Inc.

Read the full mycobacterium tuberculosis market report here:

https://www.thebusinessresearchcompany.com/report/mycobacterium-tuberculosis-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Mycobacterium Tuberculosis Market?

North America was the largest region in the mycobacterium tuberculosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mycobacterium tuberculosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mycobacterium Tuberculosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24325&type=smp

Browse Through More Reports Similar to the Global Mycobacterium Tuberculosis Market 2026, By The Business Research Company

Muscle Pain Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Muscle Tension Dysphonia Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-tension-dysphonia-treatment-global-market-report

Musculoskeletal Disorder Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795